SYNTOCINON® 6
Sponsors
Oslo University Hospital HF
Conditions
Autism spectrum disorder
Phase 2
A randomized, placebo-controlled, double-blind, 3-period cross-over study in youth with autism spectrum disorders evaluating neural plasticity and learning after a single administration of intranasal oxytocin
Not yet recruitingCTIS2023-506826-36-00
Target: 98Updated: 2025-12-03
A randomized, placebo-controlled, double-blind, 2-period cross-over study in youth with autism spectrum disorders evaluating social and repetitive behaviors after four weeks of twice daily-doses of 24IU of intranasally administered oxytocin
Not yet recruitingCTIS2024-512387-56-00
Target: 128Updated: 2024-10-09